Fintel reports that on March 30, 2026, Baird upgraded their outlook for Badger Meter (NYSE:BMI) from Neutral to Outperform.
Analyst Price Forecast Suggests 26.08% Upside
As of March 27, 2026, the average one-year price target for Badger Meter is $183.84/share. The forecasts range from a low of $137.36 to a high of $231.00. The average price target represents an increase of 26.08% from its latest reported closing price of $145.81 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Badger Meter is 647MM, a decrease of 29.37%. The projected annual non-GAAP EPS is 3.30.
What is the Fund Sentiment?
There are 510 funds or institutions reporting positions in Badger Meter. This is an decrease of 397 owner(s) or 43.77% in the last quarter. Average portfolio weight of all funds dedicated to BMI is 0.11%, an increase of 61.22%. Total shares owned by institutions decreased in the last three months by 17.69% to 29,434K shares. 
The put/call ratio of BMI is 0.24, indicating a bullish outlook.
What are Other Shareholders Doing?
Geode Capital Management holds 877K shares representing 3.00% ownership of the company. In its prior filing, the firm reported owning 873K shares , representing an increase of 0.46%. The firm decreased its portfolio allocation in BMI by 5.08% over the last quarter.
Invesco holds 766K shares representing 2.63% ownership of the company. In its prior filing, the firm reported owning 970K shares , representing a decrease of 26.65%. The firm decreased its portfolio allocation in BMI by 19.77% over the last quarter.
Pictet Asset Management Holding holds 754K shares representing 2.59% ownership of the company. In its prior filing, the firm reported owning 542K shares , representing an increase of 28.16%. The firm increased its portfolio allocation in BMI by 36.93% over the last quarter.
UBS Group holds 713K shares representing 2.44% ownership of the company. In its prior filing, the firm reported owning 377K shares , representing an increase of 47.14%. The firm decreased its portfolio allocation in BMI by 65.68% over the last quarter.
Boston Trust Walden holds 508K shares representing 1.74% ownership of the company. In its prior filing, the firm reported owning 330K shares , representing an increase of 34.99%. The firm decreased its portfolio allocation in BMI by 7.34% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
